PubMed HealthSearch

SEARCH · PubMed Health

Results for “Vitamin E”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

[E-vitamin activity of vitamin E derivatives with experimental encephalomalacia in chicks].

When adding pharmacopoeian alpha-tocopherylacetate, short-chain alpha-tocopherylacetate, alpha-tocopherylquinine, short-chain alpha-tocopherylquinone and alpha-tocopheronolactone to E-avitaminotic rations pharmacopoeian alpha-tocopherylacetate and alpha-tocopheronolactone manifest the highest E-vitamin activity in preventing encephalomalacia in chickens. The action of alpha-tocopheronolactone is not directly associated with changes in the content of vitamin E and ubiquinone in the brain and liver tissues. All the studied derivatives are effective in increasing resistance of erythrocytes to osmotic hemolysis. The data obtained evidence for a nonspecific function of vitamin E in preventing alimentary encephalomalacia in chickens as well as for the absence of disturbances in ubiquinone metabolism under conditions of the E-hypovitaminosis experimental model.

Animals

[Vitamin E levels in the ovine serum after administration of vitamin E and selenium].

The effects of drugs containing vitamin E for peroral administration (Combinal E), intramuscular injection (Erevit) and parenteral administration of a combined drug containing vitamin E and selenium (Selevit) on vitamin E levels in the ovine blood serum were studied. A uniform dose of 15 mg tocopherol acetate per 1 kg live weight was administered to the experimental animals. The level of vitamin E after the peroral administration of Combinal E was affected to a lesser extent than in swine and calves. The serum was examined before and after saponification to determine the effect of the intramuscular injection of Erevit; it was found out that tocopherol acetate prevailed in the blood serum in the first hours after such a route of administration. The best results were obtained after both subcutaneous and intramuscular administration of Selevit, the levels of free tocopherol showing high values even at the end of the experiments. These results may be made use of in determining effective preventive and therapeutic measures to do away with the white muscle disease in practice.

Administration, Oral

Mammary transfer of vitamin E in cows treated with vitamin A or linoleic acid.

The effect of an intravenous injection of vitamin A alcohol and subcutaneous injections of linoleic acid on the mammary transfer of an intravenous injection of vitamin E acetate was studied with 15 Holstein cows. The cows received either an intravenous injection of 3 g vitamin E acetate (controls), intravenous injections of 3 g vitamin E acetate and 1 million IU vitamin A alcohol, or an intravenous injection of 3 g vitamin E acetate and subcutaneous injections totaling 40 g of linoleic acid. Milk samples were at 12-h intervals, two prior to and six following treatment. The main influence of vitamin A alcohol and linoleic acid on mammary transfer of vitamin E was to delay secretion of vitamin E in milk. However, total secretion of vitamin E was not reduced by injection of either vitamin A alcohol or linoleic acid. Vitamin E injection produced substantial increases in vitamin E in milk, but less than 1% of the dose could be accounted for in the milk.

Animals

Protective effects of supplemental vitamin E against infection.

Vitamin E supplementation (dl-alpha-tocopheryl acetate except where noted) in excess of requirement significantly increased humoral immune response or disease resistance. Mice immunized with sheep red blood cells or tetanus toxoid and fed the supplemental vitamin demonstrated increased plaque-forming cells (PFC) and hemagglutinin (HA) titers. A vitamin E deficiency resulted in decreased PFC and little IgG which was partially corrected by N,N-diphenyl-p-phenylenediamine but not as effectively as by vitamin E. Hens immunized with Brucella abortus and fed different levels of the vitamin produced chicks with increased passive immunity; a biphasic antibody response to the level of the vitamin fed was noted. Vitamin E fed to nonimmunized hens was found to significantly increase the primary immune response of their immunized chicks. Feeding dl-alpha-tocopheryl acetate to guinea pigs immunized with Venezuelan equine encephalomyelitis virus resulted in no increased immunity. Injecting this form of the vitamin resulted in severe tissue reaction. However, injecting dl-alpha-tocopheryl significantly improved hemagglutinin inhibition titers. Chicks and turkeys infected with Escherichia coli and fed supplemental vitamin E had reduced mortality and increased HA titers. Sheep fed vitamin E and challenged with Chlamydia had improved weight gains and no detectable Chlamydia.

Animals

MNV-aware molecular characterization of a rare homozygous TTPA complex allele in ataxia with vitamin E deficiency.

Ataxia with vitamin E deficiency (AVED) is a rare autosomal-recessive neurological disorder caused by biallelic pathogenic variants in TTPA. Early vitamin E supplementation may prevent or limit irreversible neurological damage, but diagnosis is often delayed. Multi-nucleotide variants (MNVs) in TTPA have rarely been described and may be misinterpreted when adjacent substitutions are evaluated independently. We investigated a 34-year-old woman with childhood-onset progressive ataxia using clinical, biochemical, neuroimaging, and electrophysiological assessments. Serum vitamin E levels were measured longitudinally during supplementation. Whole-exome sequencing, read-level inspection, and Sanger sequencing were used to identify and confirm a homozygous TTPA complex allele, NM_000370.3:c. 296G > A;299 A > C, predicted to result in NP_000361.1:p. Gly99_Tyr100delinsAspSer, and to assess familial segregation. Population-database review, in silico prediction, and exploratory structure-based analysis were performed to evaluate its potential clinical relevance. The patient had markedly reduced baseline serum vitamin E levels of 0.8 µg/mL, which increased to 7.5 µg/mL after 12 months of supplementation. This biochemical correction was temporally accompanied by qualitatively observed improvements in gait stability, coordination, speech, and fine motor performance. Read-level analysis supported the presence of both substitutions on the same allele, and Sanger sequencing confirmed the homozygous complex allele in the patient and heterozygous carrier status in both parents. The affected residues are conserved and located within the CRAL-TRIO domain of α-tocopherol transfer protein. Exploratory structure-based analysis suggested altered local residue interactions; however, no functional assay was performed, and effects on protein stability, α-tocopherol binding, or transfer could not be established. This report expands the molecular spectrum of AVED by describing a homozygous TTPA complex allele and highlights the importance of MNV-aware interpretation of closely spaced substitutions. Vitamin E supplementation resulted in biochemical correction and was accompanied by possible partial clinical improvement despite initiation in adulthood. Functional studies are required to determine the precise effect of this allele on α-tocopherol transfer protein function.

Humans

Human biochemical response to ozone and vitamin E.

To determine whether vitamin E (dl-alpha-tocopherol) supplementation of the diet provides protection from inhaled oxidants such as ozone (O3) in community air pollution, its effects were studied in healthy adult volunteers, Experimental groups received 800 or 1600 IU of vitamin E for 9 wk or more; control groups received placebos. Double-blind conditions were maintained throughout the study. Biochemical parameters studied included red blood cell fragility; hematocrit and hemoglobin values; red cell glutathione concentration; and the enzymes acetylcholinesterase, glucose-6-phosphate dehydrogenase, and lactic acid dehydrogenase. No significant differences between the responses of the supplemented and placebo groups to a controlled O3 exposure (0.5 ppm for 2 h) were found for any of these parameters. The results indicate that vitamin E supplementation in humans, at the levels employed in this experiment, gives no added protection against blood biochemical effects of O3 in intermittently exercising subjects under exposure conditoins simulating summer ambient air pollution episodes.

Female

Vitamin A stimulation of parathyroid hormone: interactions with calcium, hydrocortisone, and vitamin E in bovine parathyroid tissues and effects of vitamin A in man.

The effect of vitamin A, a membrane surface-active agent, on parathyroid hormone secretion was studied in vitro, using bovine parathyroid tissue, and in vivo in man. Parathyroid tissues were incubated with vitamin A (retinol), retinoic acid, and calcium, and with hydrocortisone and vitamin E, agents that antagonize the membrane effects of vitamin A. The stimulation of parathyroid hormone release by vitamin A, 10(-6) to 10(-9) mol/1 in vitro, was dose and time dependent. Retinoic acid did not stimulate secretion. High calcium concentration, hydrocortisone, 10(-5) mol/1 and 10(-6) mol/1, and vitamin E, 10(-5) mol/1, antagonized vitamin A-induced parathyroid hormone secretion. Vitamin A increased the lysosomal cathepsin D activity of parathyroid tissues. In human studies, eleven healthy men received two intramuscular injections of vitamin A palmitate, 25 000 units each, within 24 h. In every subject, serum parathyroid hormone increased after vitamin A administration. Our studies indicate that: (1) vitamin A stimulates parathyroid hormone secretion in vitro, possibly through modification of the cell or secretion granule membrane, or through stimulation of lysosomal proteolytic activity, and (2) vitamin A increases serum parathyroid hormone in vivo, and this effect may be important in clinical states of vitamin A excess.

Adult

Modification of methylmercury neurotoxicity by vitamin E.

The protective effect of vitamin E on the neurotoxicity of methylmercury was investigated by means of light and electron microscopy. Young male golden hamsters were exposed to 2.0 ppm methylmercury chloride with or without concurrent administration of vitamin E (2.0 ppm). No toxic symptoms were observed in the vitamin E-protected animals while all the animals given methylmercury alone developed severe symptoms of methylmercury poisoning. Light microscopy revealed no significant neural damage by mercury in those animals exposed to methylmercury/vitamin E while significant neuronal necrosis could be demonstrated in both the cerebellum and calcarine cortex of the methylmercury-treated animals. Besides some accumulation of lysosomes, electron microscopy also demonstrated remarkable intactness of the cellular organelles in the nerve cells without neuronal necrosis. It appears that vitamin E has a strong protective potential against the toxicity of methylmercury.

Animals

[Histopathomorphologic changes in the organs and tissues of laboratory animals receiving an artificial diet with a low selenium and vitamin E content].

The deficiency of selenium and vitamin "E" is not infrequently noted to occur in agricultural and game-animals. Its development in humans is not ruled out. Experiments set up on mice of the CC57 lineage fed on an artificial ration with a low selenium and vitamin "E" content showed an acute selenium and vitamin "E" deficit apt to call forth profound histopathomorphological changes that become apparent following hematoxylin-eosin staining in the pancreas, liver, heart, kidneys, testes and muscular tissue. Evidence was obtained for the first time that an acute selenium and vitamin "E" deficiency leads up to a drastic fall in the content of zinc, determined by the sulfargentic method, as well as in the insular cells of the pancreas, in the renal parenchyma and in the cells of the spermatogenic epithelium of the testes.

Acute Disease

Influence of vitamin E and selenium on immune response mechanisms.

Vitamin E and selenium have both been shown to have immunostimulatory effects in a variety of species when administered in quantities in excess of established deitary requirements. Responses to each nutrient appeared to be independent of the nutrition of the other. Deficiencies of vitamin E and selenium conversely caused suppression of the immune response system, particularly, cell mediated mechanisms. Suppression was shown to be associated with serum factors coating lymphocytes from dogs deficient in vitamin E and selenium. Oral supplementation with vitamin E transformed or removed the suppressive factors, dietary selenium had no effect. In vitro peripheral lymphocyte blast transformation tests corroborated observations of in vivo studies. Reducing agents and synthetic anti-oxidants eliminated suppressive effects in vitro. Suppression was most marked in dogs fed diets highest in polyunsaturated fatty acid (PUFA) content, providing conditions most conductive to lipid peroxidation in vivo. The essential fatty acids linoleic and arachidonic have been shown to similarly influence immunoregulatory mechanisms in vivo. The effect may be a direct one since plasma membrane fluidity of lymphoid cells increases the probability of modification of cell--antigen interactions by PUFA. However, their effect may also be an indirect one. PUFA are known precursor substances of E anf F type prostaglandins which have been shown to affect immediate and delayed hypersensitivity by stimulating synthesis of cyclic AMP. More definitive studies are needed to resolve this question.

Animals

Effect of large amounts of vitamin E during pregnancy and lactation.

The effects of excessive intake of vitamin E during gestation and lactation on female rats and their progeny were studied. Pregnant rats receiving large doses of vitamin E (22.5 to 2252 mg/kg per day) had larger livers, higher levels of lipids and vitamin E in plasma, and higher concentrations of vitamin E in the livers than did controls. These deviations from normal were not, however, observed for all levels of supplementation. No obvious teratogenic effects were observed in the newborn young of the vitamin E-supplemented rats. Some eye abnormalities were seen in the older pups of rats given extremely high amounts of the vitamin. The survival rate, weight of the pups, and litter size were unaffected. However, the pups of the mothers who had received 500 mg of vitamin E per day (2252 mg/kg per day) during gestation and lactation had a much higher concentration of vitamin E in their livers and plasma than did controls. This study also confirmed the observation that vitamin E transfer across the placenta is negligible and that mammary transfer of this vitamin is quite efficient.

Animals

Increased level of L-ascorbic acid in the plasma of poly-chlorobiphenyls-treated rats and its inhibition by dietary vitamin E.

One-month-old male rats were fed a basal vitamin E deficient diet with or without 100 ppm vitamin E supplementation for 11 weeks and were injected intraperitoneally with either 500mg/kg body weight of polychlorobiphenyls (PCB) in sesame oil or equivalent amount of sesame oil. Five days after PCB treatment, the level of total L-ascorbic acid in the plasma of vitamin E deficient rats increased 69% (p less than 0.001) as compared with 26% (p less than 0.01) of the supplemented group. The dehydro form of ascorbic acid increased 111% (p less than 0.001) and 33% (p less than 0.01), respectively, in the plasma of PCB treated rats maintained on the vitamin E deficient and supplemented diets. The levels of reduced ascorbic acid and of vitamin E in plasma were not significantly altered by PCB in both groups of animals. The results suggest that dietary vitamin E may modify cellular susceptibility to PCB toxicity.

Animals